Protalix Biotherapeutics,
   
To register click here

Protalix Biotherapeutics Stock Price PLX

Company Description : The Company & its wholly-owned subsidiary, Protalix Ltd. operate as biopharmaceutical companies focused on the development and commercialization of recombinant therapeutic proteins based on the Company's proprietary ProCellExtm protein expression sys url: www.protalix.com

Name:
Protalix Biotherapeutics,
Symbol:
AMEX:PLX
Stock Market:
American Stock Exchange
Type:
Equity
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.06-0.6010.019.5310.0410.099.7110.0768085217:42:29
stock Prices on this screen are 15 minutes delayed
To register Click hereRegister for free Protalix Biotherapeutics stock prices.

Free Protalix Biotherapeutics Stock Charts

Protalix Biotherapeutics Historical Stock Chart
Protalix Biotherapeutics Historical Stock Chart
Protalix Biotherapeutics Monthly Stock Chart
Protalix Biotherapeutics Monthly Stock Chart
Protalix Biotherapeutics Intraday stock chart
Protalix Biotherapeutics Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Protalix Biotherapeutics stock Price, quotes, trades and FREE Protalix Biotherapeutics stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Protalix Biotherapeutics (PLX) and other American Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Protalix Biotherapeutics News & Message Board Discussion

Latest Protalix Biotherapeutics News Headlines
DateTimeSource
Headline
10/21/20092:40PMDJN2nd UPDATE: Genzyme 3Q Misses, Cuts '09 View Amid Plant Woes
10/15/200911:50AMDJNUPDATE: Protalix Gaucher's Treatment Passes Late-Stage Trial
10/15/20096:56AMDJNProtalix Gaucher's Treatment Passes Late-Stage Trial
08/31/20092:39PMDJNGenzyme Top Seller Faces Competition Amid Supply Issues
08/25/20099:06AMDJNFDA Gives Fast-Track Status To Protalix Drug For Gaucher's
08/17/20098:35AMDJNFDA OKs Protalix's Treatment Protocol Drug For Gaucher Disease
08/03/200911:54AMDJNIcagen Rallies, Genzyme Slides On FDA Updates
08/03/20093:05AMDJNShire Says FDA Permits Vela Use; Reports Phase III Success
07/16/20095:12AMDJNUPDATE: Shire Gets Fast-Track Approval For Gaucher-Treating Drug
07/16/20093:25AMDJNShire Gets Fast-Track Approval For Gaucher-Treating Drug
07/07/20095:11AMDJNUPDATE:Shire Seeks FDA OK To Provide Vela Amid Drug Shortage
Latest Message Board Discussions
DateTime
TitleMore
11/20/20092:48AMWeekend read, nothing new:
11/12/200912:40PMIn this one as ONE OF MY BIO
11/11/20091:39PMBetter hope it's a pullback as opposed to
11/11/200911:28AMMASSIVE recent run here folks but took my
11/05/20091:29AMDr. Aviezer at Oppenheimer conference repeated the ability
11/04/20093:38AM[quote][i]Despite the potential as a small molecule to
11/03/20092:55PMNot that simple in this case. In addition
11/03/20092:41PMConflict of interests can easily be ironed out seamlessly
11/03/20092:18PMYou're right, he served as Teva's President and
11/03/20092:12PM[i]Eli Horvitz is serving as Protalix' chairman and

Protalix Biotherapeutics Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Protalix Biotherapeutics company information and fundamental data for other USA Equity companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Protalix Biotherapeutics Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  22200 10.01 11/20/2009 4:00PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us amex plx091121 23:07 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )